The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Metformin Prevents High-Glucose–Induced Endothelial Cell Death Through a Mitochondrial Permeability Transition-Dependent Process
Abstract
Hyperglycemia-induced oxidative stress is detrimental for endothelial cells, contributing to the vascular complications of diabetes. The mitochondrial permeability transition pore (PTP) is an oxidative stress–sensitive channel involved in cell death; therefore, we have examined its potential role in endothelial cells exposed to oxidative stress or high glucose level. Metformin, an antihyperglycemic agent used in type 2 diabetes, was also investigated because it inhibits PTP opening in transformed cell lines. Cyclosporin A (CsA), the reference PTP inhibitor, and a therapeutic dose of metformin (100 μmol/l) led to PTP inhibition in permeabilized human microvascular endothelial cells (HMEC-1). Furthermore, exposure of intact HMEC-1 or primary endothelial cells from either human umbilical vein or bovine aorta to the oxidizing agent tert-butylhydroperoxide or to 30 mmol/l glucose triggered PTP opening, cytochrome c decompartmentalization, and cell death. CsA or metformin prevented all of these effects. The antioxidant N-acetyl-l-cysteine also prevented hyperglycemia-induced apoptosis. We conclude that 1) elevated glucose concentration leads to an oxidative stress that favors PTP opening and subsequent cell death in several endothelial cell types and 2) metformin prevents this PTP opening–related cell death. We propose that metformin improves diabetes-associated vascular disease both by lowering blood glucose and by its effect on PTP regulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress has been implicated in a variety of neurological diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis disease [126].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [126]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Mitochondria as the central control point of apoptosis
Desagher, S., & Martinou, J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01803-1 · Cited by 1,935
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Self-citation
Cited by
Sorted by citations
Items 101–200 of 262
Li, Z., Zhang, T., Dai, H., Liu, G., Wang, H., Sun, Y., Zhang, Y. L., & Ge, Z. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0230 · Cited by 59
“…cardiomyocytes and endothelial cells have been observed in the heart of patient with diabetes and in STZ-induced diabetic rat (Cai & Kang 2003, Adeghate 2004), and exposing to high glucose also induced the same two types of cells to death in vitro (Detaille et al. 2005, Malhotra et al. 2005).”
BackgroundRetractedMcComsey, G. A., Daar, E. S., O’Riordan, M., Collier, A. C., Kosmiski, L. A., Santana, J., Fichtenbaum, C. J., Fink, H., Sax, P. E., Libutti, D. E., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis720 · Cited by 58
“[15], ethambutol [16], or linezolid [17], or in those exposed to excessive alcohol, a known mitochondrial toxin.”
BackgroundAtherosclerosis in diabetes and insulin resistance
Reusch, J. E. B., & Draznin, B. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00620.x · Cited by 58
Dumas, J., Argaud, L., Cottet‐Rousselle, C., Vial, G., Dahout-Gonzalez, C., Détaille, D., Leverve, X. M., & Fontaine, E. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900926200 · Cited by 61
Self-citationTeng, R., Du, J., Afolayan, A. J., Eis, A., Shi, Y., & Konduri, G. G. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00200.2012 · Cited by 54
“Metformin prevents endothelial cell apoptosis via mild but specific inhibition of the mitochondrial respiratory chain complex I with decreased ROS formation (2, 9).”
BackgroundWang, Y., Wu, Z., & Hu, L. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.006 · Cited by 57
Guan, G., Han, H., Yang, Y., Jin, Y., Wang, X., & Liu, X.-M. (2014) · Endocrine · doi:10.1007/s12020-014-0186-1 · Cited by 55
An, D., Kewalramani, G., Chan, J. K. Y., Qi, D., Ghosh, S., Pulinilkunnil, T., Abrahani, A., Innis, S. M., & Rodrigues, B. B. (2006) · Diabetologia · doi:10.1007/s00125-006-0338-9 · Cited by 54
“In addition to its effect on substrate metabolism, metformin is also known to regulate endothelial cell death [20].”
BackgroundDevun, F., Walter, L., Bellière, J., Cottet‐Rousselle, C., Leverve, X. M., & Fontaine, E. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011792 · Cited by 54
“The inhibition of respiratory chain complex 1 inhibits PTP opening in U937, KB and HMEC cells [31,32,33], whereas it does not have this effect in rat liver or rat heart mitochondria [6].”
Self-citationHeme Oxygenase: A Target Gene for Anti-Diabetic and Obesity
Abraham, N. G., Tsenovoy, P. L., McClung, J. A., & Drummond, G. S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597371 · Cited by 51
“Diabetic complications have been related to abnormalities in mitochondrial function [68,71,72] as well as to increased endothelial cell death and detachment [73].”
BackgroundTakahashi, N. K., Shibata, R., Ouchi, N., Sugimoto, M., Murohara, T., & Komori, K. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.09.061 · Cited by 51
Okouchi, M., Okayama, N., & Aw, T. Y. (2009) · Current Neurovascular Research · doi:10.2174/156720209789630348 · Cited by 49
“Interestingly, metformin was shown to inhibit mitochondrial respiratory chain complex I which has been suggested to prevent mPTP opening as an adaptive response to decreased mitochondrial ROS generation and attenuated oxidative stress (Detaille et al. 2005; Marchetti et al. 2004).”
BackgroundInfluentialHypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endothelium
Nathanson, D., & Nyström, T. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.016 · Cited by 48
“It eems that metformin may also exert antioxidative effects, in as uch as it protects against high-glucose induced oxidative stress n cultured ECs through a mitochondrial permeability transition ependent pathway (Detaille et al., 2005; Guigas et al., 2004).”
BackgroundOxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus
Škrha, J., Prázný, M., Hilgertová, J., Kvasnička, J., Kalousová, M., & Zima, T. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0378-1 · Cited by 48
“generation at different steps involving inhibition of nicotinamide dinucleotide phosphate (NADPH) oxidase [11], nuclear factor kappa B (NFκB) [12] and opening of the mitochondrial permeability transition pore [13].”
BackgroundBright renoprotective properties of metformin: beyond blood glucose regulatory effects.
Nasri, H., Baradaran, A., Ardalan, M., Mardani, S., Momeni, A., & Rafieian‐Kopaei, M. (2013) · Iranian Journal of Kidney Diseases · Cited by 48
Rezabakhsh, A., Nabat, E., Yousefi, M., Montazersaheb, S., Cheraghi, O., Mehdizadeh, A., Fathi, F., Movassaghpour, A. A., Maleki‐Dizaji, N., Rahbarghazi, R., et al. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3251 · Cited by 48
A Review on The Protective Effects of Metformin in Sepsis-Induced Organ Failure.
Hassan, F. I., Didari, T., Khan, F., Niaz, K., Mojtahedzadeh, M., & Abdollahi, M. R. (2020) · PubMed Central · doi:10.22074/cellj.2020.6286 · Cited by 48
“It exerts its effect by inhibiting complex I of the electron transport chain (ETC) which increases AMP/ATP ratio and subsequently induces AMPK activation (31).”
BackgroundLi, W., Nie, S., Yao, Y.-F., Liu, X., Shao, D.-Y., Gong, D., Cui, S. W., Phillips, G. O., He, M., & Xie, M. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b03462 · Cited by 48
Hurliman, A. K., Brown, J. K., Maille, N., Mandalà, M., Casson, P. R., & Osol, G. (2015) · Endocrinology · doi:10.1210/en.2015-1159 · Cited by 44
The Effects of Metformin on Age-Related Changes in the Liver Sinusoidal Endothelial Cell
Hunt, N. J., Lockwood, G. P., Kang, S. W. S., Pulpitel, T., Clark, X., Mao, H., McCourt, P., Cooney, G. J., Wali, J. A., Couteur, F. H. L., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz153 · Cited by 45
Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 42
Yin, G. N., Kim, D., Kang, J. I., Im, Y., Lee, D. S., Han, A. R., Ock, J., Choi, M. J., Kwon, M., Limanjaya, A., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00773-5 · Cited by 44
Targeting oxidative stress in preeclampsia
Afrose, D., Alfonso-Sánchez, S., & McClements, L. (2024) · Hypertension in Pregnancy · doi:10.1080/10641955.2024.2445556 · Cited by 45
“Also, metformin prevents hyperglycemia-induced endothelial cell death by stabilizing the mitochondrial permeability transition, highlighting metformin’s protective role against oxidative injury to endothelial cells, which is relevant to preeclampsia (162).”
The pleiotropic effects of metformin: time for prospective studies
Bromage, D. I., & Yellon, D. M. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0273-5 · Cited by 42
Tsai, H., Lin, C.-P., Huang, P.-H., Li, S., Chen, J.-S., Lin, F., Chen, J., & Lin, S. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6384759 · Cited by 40
“These findings are consistent with previous reports and suggest that activation of CoQ10 might reduce hyperglycemia-induced mitochondrial dysfunction and promote mitochondrial biogenesis in EPCs exposed to high glucose [27, 28].”
ResultProtective effect of metformin on testicular ischemia/reperfusion injury in rats
Asghari, A., Akbari, G., Meghdadi, A., & Mortazavi, P. (2016) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020160060000008 · Cited by 40
Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors
Garelja, M. L., Au, M., Brimble, M. A., Gingell, J. J., Hendrikse, E. R., Lovell, A., Prodan, N., Sexton, P. M., Siow, A., Walker, C. S., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00083 · Cited by 40
Hartman, M. H. T., Prins, J. K. B., Schurer, R. A. J., Lipšic, E., Lexis, C. P. H., van der Horst‐Schrivers, A. N. A., van Veldhuisen, D. J., van der Horst, I. C. C., & van der Horst, I. C. C. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1140-z · Cited by 40
Samuel, S. M., Ghosh, S., Majeed, Y., Arunachalam, G., Emara, M. M., Ding, H., & Triggle, C. R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.001 · Cited by 37
Lv, Q., Zhen, Q., Liu, L., Gao, R., Yang, S., Huang, Z., Goswami, R., & Li, Q. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.003 · Cited by 37
Kumar, A., Al-Sammarraie, N., DiPette, D. J., & Singh, U. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2606 · Cited by 38
Gujjala, S., Putakala, M., Nukala, S., Manjunatha, B., Ramaswamy, R., & Desireddy, S. (2016) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.01.013 · Cited by 36
Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity
Chade, A., & Hall, J. E. (2016) · American Journal of Nephrology · doi:10.1159/000452365 · Cited by 36
Endoplasmic Reticulum-Mitochondria Crosstalk and Beta-Cell Destruction in Type 1 Diabetes
Vig, S., Lambooij, J. M., Zaldumbide, A., & Guigas, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669492 · Cited by 38
Self-citationTargosz‐Korecka, M., Malek-Zietek, K. E., Klóska, D., Rajfur, Z., Stępień, E. Ł., Grochot‐Przeczek, A., & Szymoński, M. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129533 · Cited by 32
Endotheliopathy in the metabolic syndrome: Mechanisms and clinical implications
Furuta, K., Tang, X., Islam, S., Tapia, A., Chen, Z. B., & Ibrahim, S. H. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108372 · Cited by 36
Huang, Q., Li, Q., Chen, Y., Li, L., Liu, L., Lei, S., Chen, H., Peng, W., & He, M. L. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0477-9 · Cited by 33
Intestinal oxygen utilisation and cellular adaptation during intestinal ischaemia–reperfusion injury
Barakakis, P. A., Mavridis, T., Chlorogiannis, D., Barakakis, G., Laou, E., Sessler, D. I., Gkiokas, G., & Chalkias, A. F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70136 · Cited by 32
Li, F., Luo, J., Wu, Z., Xiao, T., Zeng, O., Li, L., Li, Y., & Yang, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5289 · Cited by 33
“Moreover, the effect of myocardial apoptosis caused by hyperglycemia was also demonstrated in vitro (65,66).”
Sun, S., Liu, L., Tian, X., Guo, Y., Cao, Y., Mei, Y., & Wang, C. (2019) · Planta Medica · doi:10.1055/a-0837-0975 · Cited by 32
“Previous studies have evidenced that icariin and Met can keep the normal structure of the mitochondria membrane [18,27].”
BackgroundLi, R., 杨凌712100,中国, 西., Zhu, Z., Zheng, Y., Lv, Y., Tian, X., Wu, D., Wang, Y., Zeng, W., & 成都611100,中国, 四. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.074 · Cited by 33
Ommati, M. M., Mohammadi, H., Mousavi, K., Azarpira, N., Farshad, O., Dehghani, R., Najibi, A., Kamran, S., Niknahad, H., & Heidari, R. (2020) · Liver Research · doi:10.1016/j.livres.2020.12.001 · Cited by 30
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis
Wiernsperger, N. F., Al‐Salameh, A., Cariou, B., & Lalau, J. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101359 · Cited by 31
“MET inhibited MTP opening and the release of cytochrome c in neurons [212], hyperglycaemia-cultured endothelial cells [213], pancre-”
Self-citationLimanjaya, A., Yin, G. N., Hong, S., Kang, J., Gho, Y. S., Suh, J., & Ryu, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72243 · Cited by 30
Morota, S., Månsson, R., Hansson, M. J., Kasuya, K., Shimazu, M., Hasegawa, E., Yanagi, S., Omi, A., Uchino, H., & Elmér, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.036 · Cited by 31
Gujjala, S., Putakala, M., Gangarapu, V., Nukala, S., Bellamkonda, R., Ramaswamy, R., & Desireddy, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.031 · Cited by 30
An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis
Markowicz-Piasecka, M., Sadkowska, A., Huttunen, K. M., Podsiedlik, M., Mikiciuk‐Olasik, E., & Sikora, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172984 · Cited by 31
Stem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions
Akter, S., Choubey, M., Mohib, M. M., Arbee, S., Sagor, M. A. T., & Mohiuddin, M. S. (2023) · Brain Sciences · doi:10.3390/brainsci13020255 · Cited by 29
Metformin and respiratory chain complex I: the last piece of the puzzle?
Fontaine, E. M. (2014) · Biochemical Journal · doi:10.1042/bj20141020 · Cited by 29
Self-citationJoshi, M. S., Williams, D., Horlock, D., Samarasinghe, T. D., Andrews, K. L., Jefferis, A., Berger, P. J., Chin-Dusting, J. P. F., & Kaye, D. M. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114565629 · Cited by 29
Ge, Z., Ionova, I. A., Vladic, N., Pravdić, D., Hirata, N., Vasquez-Vivar, J. M., Pratt, P. F., Warltier, D. C., Pieper, G. M., & Kersten, J. R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr079 · Cited by 28
Review: 50 years later: is metformin a vascular drug with antidiabetic properties?
Wiernsperger, N. F. (2007) · The British Journal of Diabetes · doi:10.1177/14746514070070050201 · Cited by 28
“Indeed metformin inhibits opening of the mitochondrial transition pore and cytochrome C release into the cytoplasm.(65,66)”
BackgroundSelf-citationHan, X., Wang, B., Sun, Y., Huang, J., Wang, X., Ma, W., Zhu, Y., Xu, R., Jin, H. L., & Liu, N. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01266 · Cited by 28
“Studies have indicated that diabetes or highglucose (HG) levels trigger multiple endothelial dysfunctions, such as dysregulated endothelial cell proliferation, migration, and apoptosis (Baumgartner-Parzer et al., 1995; Tousoulis et al., 2013; Dong et al., 2017).”
Li, Y., Lou, N., Liu, X., Zhuang, X., & Chen, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116755 · Cited by 27
Markowicz-Piasecka, M., Huttunen, K. M., Broncel, M., & Sikora, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-43083-z · Cited by 27
Wang, B., Wang, J., Jiang, Y. G., Quan, Q., Ji, R., Tan, P., Han, J., & Liu, Y. (2016) · Molecules · doi:10.3390/molecules21111496 · Cited by 27
“However, AMPK activators could increase cell survival, such as metformin and dithiolethiones [38,39].”
BackgroundAlpha-mangostin decreased cellular senescence in human umbilical vein endothelial cells
Tousian, H., Razavi, B. M., & Hosseinzadeh, H. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00305-z · Cited by 26
The Hormetic Effect of Metformin: “Less Is More”?
Panfoli, I., Puddu, A., Bertola, N., Ravera, S., & Maggi, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126297 · Cited by 29
“For example, MTF used at micromolar concentration inhibits the mPTP opening by an AKT-dependent pathway [36], preventing the associated ROS generation and the release of cytochrome c [37].”
BackgroundGhatak, S. B., Dhamecha, P. S., Bhadada, S. V., & Panchal, S. J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.029 · Cited by 26
“, 2006), antioxidant effects like prevention of mitochondrial permeability transition pore opening (Detaille et al., 2005), reduction in radical oxygen species production (Gallo et al.”
BackgroundImpact of metformin use on the prognostic value of lactate in sepsis
Green, J. P., Berger, T., Garg, N., Suarez, A. E., Hagar, Y., Radeos, M. S., & Panacek, E. A. (2012) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2012.01.014 · Cited by 25
Metformin and Glaucoma—Review of Anti-Fibrotic Processes and Bioenergetics
Hurley, D. J., Irnaten, M., & O'Brien, C. J. (2021) · Cells · doi:10.3390/cells10082131 · Cited by 24
Liu, J., Aylor, K. W., Chai, W., Barrett, E. J., & Liu, Z. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00240.2021 · Cited by 27
Yin, G. N., Park, S., Song, K., Limanjaya, A., Ghatak, K., Minh, N. N., Ock, J., Ryu, J., & Suh, J. ‐. (2016) · Andrology · doi:10.1111/andr.12307 · Cited by 25
“…model for diabetes-induced angiopathy, primary cultured MCECs and MCPs were serum-starved for 24 h and were exposed to the normal-glucose (5 mmoL, Sigma- Aldrich) or high-glucose (30 mmoL) condition for 48 h as previously described (Poczatek et al., 2000; Li et al., 2003; Detaille et al., 2005).”
MethodUse of metformin for prevention of ovarian hyperstimulation syndrome: a novel approach
Khattab, S., Foutouh, I. A., Mohesn, I. A., Metwally, M. A., & Moaz, M. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60614-1 · Cited by 24
Metformin Effect on Endocan Biogenesis in Human Endothelial Cells Under Diabetic Condition
Zolali, E., Rezabakhsh, A., Nabat, E., Jaberi, H., Rahbarghazi, R., & Garjani, A. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.012 · Cited by 23
Markowicz-Piasecka, M., Huttunen, K. M., Sadkowska, A., & Sikora, J. (2019) · Molecules · doi:10.3390/molecules25010125 · Cited by 23
“Most of the current literature concentrates on the effects of metformin on the apoptosis of endothelial cells [40,41].”
BackgroundYin, G. N. (2022) · Korean journal of urology · doi:10.4111/icu.20220038 · Cited by 20
“For glucose condition studies, the MCECs or MCPs were serum-starved for 24 hours and then exposed to normal glucose (NG, 5 mM glucose, Sigma-Aldrich) or HG (30 mM glucose) conditions for 3 days at 37°C in a humidified 5% CO2 atmosphere [14].”
MethodOck, J., Suh, J., Hong, S., Kang, J., Yin, G. N., & Ryu, J. (2022) · Andrology · doi:10.1111/andr.13234 · Cited by 19
Avcı, O., Özdemir, E., Taşkıran, A. Ş., İnan, Z. D. Ş., & Gürsoy, S. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02283-7 · Cited by 19
Microcirculation and Mitochondria: The Critical Unit
Wang, G., Lian, H., Zhang, H., & Wang, X. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206453 · Cited by 19
“Nevertheless, it must be used cautiously in patients with shock because of its potential for causing renal damage and serious side effects, such as hyperlactacidemia [82].”
BackgroundPlowman, T. J., Christensen, H., Aiges, M., Fernandez, E., Shah, M. H., & Ramana, K. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105190 · Cited by 20
“Further, Detaille et al. [50] have shown that metformin prevents endothelial cell death by regulating the mitochondrial permeability transition pore.”
BackgroundYin, G. N., Wu, J., Cui, Y., Lin, C., Shi, L., Gao, Z., Suh, J., Ryu, J., & Jin, H. (2020) · Korean journal of urology · doi:10.4111/icu.20200272 · Cited by 18
Shen, D., Ye, X., Li, J., Hao, X., Jin, L., Jin, Y., Tong, L., & Gao, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158552 · Cited by 18
Metformin: A Promising Antidiabetic Medication for Cancer Treatment
Mu, W., Jiang, Y., Liang, G., Feng, Y., & Qu, F. (2022) · Current Drug Targets · doi:10.2174/1389450124666221104094918 · Cited by 18
Karakaş, S., Kaya, C., Güraslan, H., Sakız, D., Çaypınar, S. S., Cengiz, H., Ekin, M., & Yaşar, L. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1803-196 · Cited by 18
“Previous ischemia-reperfusion studies performed with metformin in different tissues have shown that metformin protects tissues by reducing lipid peroxidase, MDA, ROS, and inflammatory cytokines [33,34].”
BackgroundYin, G. N., Ock, J., Choi, M. J., Limanjaya, A., Ghatak, K., Song, K., Kwon, M.-H., Suh, J., & Ryu, J. (2020) · Korean journal of urology · doi:10.4111/icu.20200119 · Cited by 18
Metformin and atorvastatin reduce adhesion formation in a rat uterine horn model
Yılmaz, B., Aksakal, O., Gungor, T., Şirvan, L., Süt, N., Kelekçi, S., Soysal, S., & Mollamahmutoğlu, L. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60106-x · Cited by 18
Metformin and renal injury protection.
Rafieian-Kopaie, M. (2013) · PubMed Central · doi:10.12861/jrip.2013.29 · Cited by 17
“Various studies have suggested that AMPK activation by metformin is secondary to its effect on the mitochondria as the primary target of this agent (4-10).”
BackgroundTao, L., Fan, X., Sun, J., & Zhang, Z. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.119015 · Cited by 18
Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target
Ravi, S., Punabaka, J., Shanmugam, B., Ganjikunta, V. S., Shanmugam, K. R., & Kesireddy, S. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200730221035 · Cited by 15
N-Acetylcysteine Enhances the Recovery of Ischemic Limb in Type-2 Diabetic Mice
Zhu, Q., Liu, X., Zhu, Q., Liu, Z., Yang, C., Wu, H., Zhang, L., Xia, X., Wang, M., Hao, H., et al. (2022) · Antioxidants · doi:10.3390/antiox11061097 · Cited by 15
Vogt, J. A., Wachter, U. A., Wagner, K., Calzia, E., Gröger, M., Weber, S., Stahl, B., Georgieff, M., Asfar, P., Fontaine, E. M., et al. (2014) · Intensive Care Medicine Experimental · doi:10.1186/2197-425x-2-19 · Cited by 15
“As a whole, these findings agree with various previous reports that hyperglycemia causes liver tissue apoptosis [39-42], which can be prevented by anti-diabetic drugs such as metformin [20,21,43], even during acute stress states [44].”
InfluentialSelf-citationMicrocirculation vs. Mitochondria—What to Target?
Merz, T., Denoix, N., Huber-Lang, M. S., Singer, M., Radermacher, P., & McCook, O. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00416 · Cited by 15
“Metformin has been shown to be beneficial for the attenuation of mitochondrial transition pore opening (99), stimulation of mitochondrial biogenesis and reduction of mitochondrial ROS production, but has to be used with caution in shock patients due to its potentially severe side effects, i.”
BackgroundInsulin resistance in NSCLC: unraveling the link between development, diagnosis, and treatment
Zhan, S., Wang, L., Wang, W., & Li, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1328960 · Cited by 14
Metformin as a cellular protector; a synoptic view of modern evidences.
Wiernsperger, N. F. (2015) · Europe PMC (PubMed Central) · Cited by 13
Self-citationDang, K., Hui, Y.-N., & Du, H. (2021) · International Journal of Ophthalmology · doi:10.18240/ijo.2021.08.20 · Cited by 14
Novoselova, E. G. (2024) · Cellular Physiology and Biochemistry · doi:10.33594/000000690 · Cited by 13
Wang, L., Yu, J., Yang, H., Peng, C. Y., Zhang, C., Tao, X., & Xie, H. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445587 · Cited by 12
Oxazolidinones and Human Immunodeficiency Virus
Madariaga, M. G., & Swindells, S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01357-06 · Cited by 12
Zhang, T.-X., Xu, J., Peng, F., Chai, D., & Lin, J. (2012) · Blood Pressure · doi:10.3109/08037051.2012.732761 · Cited by 11
Sha, T., Zhang, Y., Li, C., Lei, G., Wu, J., Li, X., Yang, Z., Zeng, C., & Wei, J. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab291 · Cited by 12
Heat Shock Protein 70 in Penile Neurovascular Regeneration Requires Cystathionine Gamma-Lyase
Ghatak, K., Yin, G. N., Hong, S., Kang, J., Suh, J., & Ryu, J.-K. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.210249 · Cited by 10
Škrha, J., Gáll, J., Buchal, R., Sedláčková, E., & Plátenı́k, J. (2011) · Folia Biologica · doi:10.14712/fb2011057030096 · Cited by 11
“Even though the concentration required to produce these effects (30 mM) seems exceedingly high, previous studies modelling hyperglycaemic damage to cell cultures used the same glucose level (Detaille et al., 2005; Ksiazek et al., 2008).”
BackgroundBruss, M. D., Elliehausen, C. J., Clark, J. P., Minton, D. M., & Konopka, A. R. (2025) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00432.2025 · Cited by 11
Metformin induced expression of Hsp60 in human THP-1 monocyte cells
Tsuei, A.-C., & Martinus, R. D. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-011-0282-6 · Cited by 10
Wang, H., Yao, Y., Liu, J., Cao, Y., Si, C., Zheng, R., Zeng, C., Huaimin, G., & Li, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.080 · Cited by 10
Limanjaya, A., Choi, M. J., Yin, G. N., Ock, J., Kwon, M.-H., Hong, S., Kang, J., Suh, J., & Ryu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-04873-w · Cited by 9
Tousian, H., Razavi, B. M., & Hosseinzadeh, H. (2020) · PubMed Central · doi:10.22038/ijbms.2020.40651.9612 · Cited by 9
“Hyperglycemia increases reactive oxygen species (ROS) production through mitochondria and induces angiopathy (2).”
BackgroundRenoprotective effects of metformin
Nasri, H. (2013) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-21-36 · Cited by 8
“Various data indicates that AMPK activation by metformin is secondary to its effect on the mitochondria as the primary target of this agent [5,6,11].”
BackgroundResultInfluentialEnergy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart
Heinz, S., Freyberger, A., Lawrenz, B., Schladt, L., Schmuck, G., & Ellinger-Ziegelbauer, H. C. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02519-1 · Cited by 8
Metadata
- Authors
- Detaille, D., Guigas, B., Chauvin, C., Batandier, C., Fontaine, E., Wiernsperger, N., & Leverve, X.
- Affiliations
- Laboratoire de Bioénergétique Fondamentale et Appliquée, Institut National de la Santé et de la Recherche Médicale EMI-0221, Université Joseph Fourier, Grenoble, France
- Inserm (FR)
- Merck Serono S.A.S. (France) (FR)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-07-01
- Volume
- 54
- Issue
- 7
- Pages
- 2179-2187
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2163301537
- Cited by
- 263
- References
- 40
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 10 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 19 · 2019: 19 · 2018: 12 · 2017: 7 · 2016: 16 · 2015: 17 · 2014: 12 · 2013: 12 · 2012: 15
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, mitochondrial permeability transition pore, endothelial cell death, hyperglycemia, oxidative stress, cyclosporine, cytochrome c release, apoptosis, tert-butyl hydroperoxide, N-acetylcysteine, diabetic vascular complications, type 2 diabetes, microvascular endothelial cells
- MeSH terms
- Cell Line, Endothelium, Vascular, Glucose, Humans, Metformin, Microcirculation, Mitochondria, Permeability, Skin, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review